Not at all. Trial and BLA was always up to 18. You often hear comments regarding the under 12 group because they have no approved treatment options.
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L, page-22
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.35 |
Change
0.100(8.03%) |
Mkt cap ! $1.575B | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.40 | $1.27 | $9.650M | 7.166M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 10773 | $1.34 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.35 | 78262 | 6 |
View Market Depth
| Last trade - 12.19pm 03/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |